Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2003-06-02
2010-06-15
Silverman, Eric E. (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S422000, C514S772000, C514S772300, C514S772400
Reexamination Certificate
active
07736665
ABSTRACT:
The present invention provides compositions, methods, and kits for treatment of opiate addiction and pain. The invention provides a biocompatible nonerodible polymeric device which releases buprenorphine continuously with generally linear release kinetics for extended periods of time. Buprenorphine is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with buprenorphine.
REFERENCES:
patent: 3689634 (1972-09-01), Kliment et al.
patent: 3717639 (1973-02-01), Neumeyer
patent: 3814768 (1974-06-01), Fishman
patent: 4069307 (1978-01-01), Higuchi et al.
patent: 4148871 (1979-04-01), Pitt et al.
patent: 4351337 (1982-09-01), Sidman
patent: 4450150 (1984-05-01), Sidman
patent: 4464378 (1984-08-01), Hussain
patent: 4535157 (1985-08-01), Meltzer et al.
patent: 4543256 (1985-09-01), Neumeyer
patent: 4582835 (1986-04-01), Lewis et al.
patent: 4599342 (1986-07-01), LaHann
patent: 4622219 (1986-11-01), Haynes
patent: 4661492 (1987-04-01), Lewis et al.
patent: 4670014 (1987-06-01), Huc et al.
patent: 4678809 (1987-07-01), Phillips
patent: 4692451 (1987-09-01), Dodman et al.
patent: 4725442 (1988-02-01), Haynes
patent: 4818542 (1989-04-01), DeLuca et al.
patent: 4844903 (1989-07-01), Seth
patent: 4861627 (1989-08-01), Mathiowitz et al.
patent: 4882335 (1989-11-01), Sinclair
patent: 4883666 (1989-11-01), Sabel et al.
patent: 4897268 (1990-01-01), Tice et al.
patent: 4898733 (1990-02-01), DePrince et al.
patent: 4935428 (1990-06-01), Lewis
patent: 4957119 (1990-09-01), de Nijs
patent: 4962091 (1990-10-01), Eppstein et al.
patent: 4983586 (1991-01-01), Bodor
patent: 4994281 (1991-02-01), Muranishi et al.
patent: 5024998 (1991-06-01), Bodor
patent: 5069909 (1991-12-01), Sharma et al.
patent: 5075341 (1991-12-01), Mendelson et al.
patent: 5086058 (1992-02-01), Sinclair et al.
patent: 5114718 (1992-05-01), Damani
patent: 5114719 (1992-05-01), Sabel et al.
patent: 5128145 (1992-07-01), Edgren et al.
patent: 5149538 (1992-09-01), Granger et al.
patent: 5156844 (1992-10-01), Aebischer et al.
patent: 5211951 (1993-05-01), Sparer et al.
patent: 5219858 (1993-06-01), Parnell
patent: 5236714 (1993-08-01), Lee et al.
patent: 5238933 (1993-08-01), Catz et al.
patent: 5240711 (1993-08-01), Hille et al.
patent: 5298017 (1994-03-01), Theeuwes et al.
patent: 5478577 (1995-12-01), Sackler et al.
patent: 5486362 (1996-01-01), Kitchell et al.
patent: 5503844 (1996-04-01), Kwiatek et al.
patent: 5562917 (1996-10-01), Durif et al.
patent: 5574052 (1996-11-01), Rose et al.
patent: 5580578 (1996-12-01), Oshlack et al.
patent: 5580876 (1996-12-01), Crain et al.
patent: 5585460 (1996-12-01), Yamada et al.
patent: 5587381 (1996-12-01), Sinclair
patent: 5601835 (1997-02-01), Sabel et al.
patent: 5604198 (1997-02-01), Poduslo et al.
patent: 5618553 (1997-04-01), Kelleher
patent: 5618555 (1997-04-01), Tokuda et al.
patent: 5629014 (1997-05-01), Kwiatek et al.
patent: 5633000 (1997-05-01), Grossman et al.
patent: 5650173 (1997-07-01), Ramstack et al.
patent: 5651986 (1997-07-01), Brem et al.
patent: 5654008 (1997-08-01), Herbert et al.
patent: 5703101 (1997-12-01), Rose et al.
patent: 5718921 (1998-02-01), Mathiowitz et al.
patent: 5726190 (1998-03-01), Rose et al.
patent: 5732717 (1998-03-01), Watanabe et al.
patent: 5750136 (1998-05-01), Scholz et al.
patent: 5756483 (1998-05-01), Merkus
patent: 5770231 (1998-06-01), Mesens et al.
patent: 5770606 (1998-06-01), El-Rashidy et al.
patent: 5851547 (1998-12-01), Fujioka et al.
patent: 5858388 (1999-01-01), Grossman et al.
patent: 5877224 (1999-03-01), Brocchini et al.
patent: 5919473 (1999-07-01), Elkhoury
patent: 5935975 (1999-08-01), Rose et al.
patent: 5939094 (1999-08-01), Durif et al.
patent: 5965168 (1999-10-01), Mesens et al.
patent: 5968547 (1999-10-01), Reder et al.
patent: 5968551 (1999-10-01), Oshlack et al.
patent: 5980927 (1999-11-01), Nelson et al.
patent: 5980948 (1999-11-01), Goedemoed et al.
patent: 5994363 (1999-11-01), El-Rashidy et al.
patent: 6001845 (1999-12-01), Estok
patent: 6004962 (1999-12-01), Gooberman
patent: 6004969 (1999-12-01), Hu
patent: 6007841 (1999-12-01), Caruso
patent: 6011043 (2000-01-01), Estok
patent: 6117454 (2000-09-01), Kreuter et al.
patent: 6126956 (2000-10-01), Grossman et al.
patent: 6136818 (2000-10-01), Estok
patent: 6203813 (2001-03-01), Gooberman
patent: 6228863 (2001-05-01), Palermo et al.
patent: 6271240 (2001-08-01), Simon
patent: 6342250 (2002-01-01), Masters
patent: 6344212 (2002-02-01), Reder et al.
patent: 6461485 (2002-10-01), Mizouchi et al.
patent: 6495155 (2002-12-01), Tice et al.
patent: 6512009 (2003-01-01), Daoust et al.
patent: 6541021 (2003-04-01), Johnson et al.
patent: 6613358 (2003-09-01), Randolph et al.
patent: 7270830 (2007-09-01), Reidenberg et al.
patent: 2001/0036469 (2001-11-01), Gooberman
patent: 2002/0034534 (2002-03-01), Barr et al.
patent: 2002/0198574 (2002-12-01), Gumpert
patent: 2003/0039689 (2003-02-01), Chen et al.
patent: 2003/0211157 (2003-11-01), Simon
patent: 2004/0009222 (2004-01-01), Chou et al.
patent: 2004/0024006 (2004-02-01), Simon
patent: 2005/0245541 (2005-11-01), Ehrich et al.
patent: 2007/0275031 (2007-11-01), Patel et al.
patent: 2008/0026031 (2008-01-01), Patel et al.
patent: 0 069 600 (1983-01-01), None
patent: 0 226 061 (1987-06-01), None
patent: 0 226 061 (1987-06-01), None
patent: 0 226 061 (1987-06-01), None
patent: 0 478 671 (1992-04-01), None
patent: 0 531 415 (1993-03-01), None
patent: 0 945 133 (1999-09-01), None
patent: 3-193732 (1991-08-01), None
patent: WO-89/05632 (1989-06-01), None
patent: WO-90/15637 (1990-12-01), None
patent: WO-91/18605 (1991-12-01), None
patent: WO-96/00537 (1996-01-01), None
patent: WO-98/20684 (1998-05-01), None
patent: WO 00/19976 (2000-04-01), None
patent: WO 00/35456 (2000-06-01), None
patent: WO-00/72827 (2000-12-01), None
patent: WO-00/72827 (2000-12-01), None
patent: WO-03/101358 (2003-12-01), None
patent: WO-2004/089375 (2004-10-01), None
patent: WO-2007/139744 (2007-12-01), None
PDR Drug Information for Buprenorphine Hydrochloride, downloaded from the world wide web on Jul. 20, 2006.
Patel, R. (2001). “Buprenorphine Implants: Novel Treatment for Opiate Dependence,” Poster Presentation:Pharmaceutical Congress of the Americas: Orlando, FL, Mar. 24-29, 2001, three pages.
Ciraulo, D.A. et al. (2006). “Pharmacokinetics and Pharmacodynamics of Multiple Sublingual Buprenorphine Tablets in Dose-Escalation Trials,”Pharmacokinetics and Pharmacodynamics46:179-192.
Cowan, A. et al. (1977). “The Animal Pharmacology of Buprenorphine, an Oripavine Analgesic Agent,”Br. J. Pharmac. 60:547-554.
Gueye, P.N. et al. (2001). “Lack of Effect of Single High Doses of Buprenorphine on Arterial Blood Gases in the Rat,”Toxicological Sciences62:148-154.
Lesser, G.L. et al. (May/Jun. 1996). “In Vitro and In Vivo Studies of Subcutaneous Hydromorphone Implants Designed for the Treatment of Cancer Pain,”Pain65(2,3):265-272.
McAleer, S.D. et al. (Oct. 24, 2003). “Pharmacokinetics of High Dose Buprenorphine Following Single Administration of Sublingual Tablet Formulations in Opiod Naive Healthy Male Volunteers under a Naltrexone Block,”Drug and Alcohol Dependence72(1):75-83.
Ohtani, M. et al. (Feb. 1995). “Comparative Analysis of Buprenorphine-and Norbuprenorphine -Induced Analgesic Effects Based on Pharmacokinetic-Pharmacodynamic Modeling,”Journal of Pharmacology and Experimental Therapeutics272(2):505-509.
Walsh, S.L. et al. (May 1994). “Clinical Pharmacology of Buprenorphine: Ceiling Effects at High Doses,”Clinical Pharmacology&Therapeutics55(5):569-580.
International Search Report mailed on Sep. 18, 2008, for PCT Application No. PCT/US2007/012046, filed on May 18, 2007, eight pages.
Written Opinion mailed Sep. 18, 2008, for PCT Application No. PCT/US2007/012046, filed on May 18, 2007, nine pages.
Anonymous (2005). “The Use of Transdermal Opioids in Patents with Malignant Pain Requires and Individual
Bucalo Louis R.
Patel Rajesh A.
Morrison & Foerster / LLP
Silverman Eric E.
Titan Pharmaceuticals, Inc.
LandOfFree
Implantable polymeric device for sustained release of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Implantable polymeric device for sustained release of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Implantable polymeric device for sustained release of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4186285